This study demonstrated that the AGS-associated genetic mutation encoding the Adar D1113H replacement in the ADAR1 catalytic domain resulted in early-onset neuropathogenesis and illuminated the molecular consequence of this mutation in RNA transcript editing and the signaling pathway underlying the disease development. The gene discussed is ADAR; the disease is Aicardi-Goutieres syndrome.